• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质网络分析揭示了肌萎缩侧索硬化症和脊髓性肌萎缩症中失调过程的功能连通性。

Protein Network Analysis Reveals a Functional Connectivity of Dysregulated Processes in ALS and SMA.

作者信息

Kubinski Sabrina, Claus Peter

机构信息

Institute of Neuroanatomy and Cell Biology, Hannover Medical School, Hannover, Germany.

Center for Systems Neuroscience (ZSN), Hannover, Germany.

出版信息

Neurosci Insights. 2022 Mar 28;17:26331055221087740. doi: 10.1177/26331055221087740. eCollection 2022.

DOI:10.1177/26331055221087740
PMID:35372839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8966079/
Abstract

Spinal Muscular Atrophy (SMA) and Amyotrophic Lateral Sclerosis (ALS) are neurodegenerative diseases which are characterized by the loss of motoneurons within the central nervous system. SMA is a monogenic disease caused by reduced levels of the Survival of motoneuron protein, whereas ALS is a multi-genic disease with over 50 identified disease-causing genes and involvement of environmental risk factors. Although these diseases have different causes, they partially share identical phenotypes and pathomechanisms. To analyze and identify functional connections and to get a global overview of altered pathways in both diseases, protein network analyses are commonly used. Here, we used an tool to test for functional associations between proteins that are involved in actin cytoskeleton dynamics, fatty acid metabolism, skeletal muscle metabolism, stress granule dynamics as well as SMA or ALS risk factors, respectively. In network biology, interactions are represented by edges which connect proteins (nodes). Our approach showed that only a few edges are necessary to present a complex protein network of different biological processes. Moreover, Superoxide dismutase 1, which is mutated in ALS, and the actin-binding protein profilin1 play a central role in the connectivity of the aforementioned pathways. Our network indicates functional links between altered processes that are described in either ALS or SMA. These links may not have been considered in the past but represent putative targets to restore altered processes and reveal overlapping pathomechanisms in both diseases.

摘要

脊髓性肌萎缩症(SMA)和肌萎缩侧索硬化症(ALS)是神经退行性疾病,其特征是中枢神经系统内运动神经元的丧失。SMA是一种单基因疾病,由运动神经元存活蛋白水平降低引起,而ALS是一种多基因疾病,已鉴定出50多个致病基因,并涉及环境风险因素。尽管这些疾病病因不同,但它们部分共享相同的表型和发病机制。为了分析和识别功能联系,并全面了解两种疾病中改变的通路,通常使用蛋白质网络分析。在这里,我们使用一种工具来测试分别参与肌动蛋白细胞骨架动力学、脂肪酸代谢、骨骼肌代谢、应激颗粒动力学以及SMA或ALS风险因素的蛋白质之间的功能关联。在网络生物学中,相互作用由连接蛋白质(节点)的边表示。我们的方法表明,只需几条边就能呈现一个由不同生物过程组成的复杂蛋白质网络。此外,在ALS中发生突变的超氧化物歧化酶1和肌动蛋白结合蛋白原肌球蛋白1在上述通路的连通性中起核心作用。我们的网络表明了ALS或SMA中所描述的改变过程之间的功能联系。这些联系过去可能未被考虑,但代表了恢复改变过程和揭示两种疾病重叠发病机制的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ed/8966079/63bd030e916f/10.1177_26331055221087740-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ed/8966079/63bd030e916f/10.1177_26331055221087740-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ed/8966079/63bd030e916f/10.1177_26331055221087740-fig1.jpg

相似文献

1
Protein Network Analysis Reveals a Functional Connectivity of Dysregulated Processes in ALS and SMA.蛋白质网络分析揭示了肌萎缩侧索硬化症和脊髓性肌萎缩症中失调过程的功能连通性。
Neurosci Insights. 2022 Mar 28;17:26331055221087740. doi: 10.1177/26331055221087740. eCollection 2022.
2
The Actin Cytoskeleton in SMA and ALS: How Does It Contribute to Motoneuron Degeneration?SMA 和 ALS 中的肌动蛋白细胞骨架:它如何导致运动神经元退化?
Neuroscientist. 2018 Feb;24(1):54-72. doi: 10.1177/1073858417705059. Epub 2017 May 1.
3
Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients.肌肉特异性 microRNAs 失调作为 ALS、SMA 和 SBMA 肌肉萎缩的共同致病特征:来自动物模型和人类患者的证据。
Int J Mol Sci. 2021 May 26;22(11):5673. doi: 10.3390/ijms22115673.
4
Multi-Study Proteomic and Bioinformatic Identification of Molecular Overlap between Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA).肌萎缩侧索硬化症(ALS)与脊髓性肌萎缩症(SMA)分子重叠的多研究蛋白质组学和生物信息学鉴定
Brain Sci. 2018 Dec 4;8(12):212. doi: 10.3390/brainsci8120212.
5
Protein network analysis to prioritize key genes in amyotrophic lateral sclerosis.蛋白质网络分析以确定肌萎缩侧索硬化症中的关键基因优先级。
IBRO Neurosci Rep. 2021 Dec 7;12:25-44. doi: 10.1016/j.ibneur.2021.12.002. eCollection 2022 Jun.
6
Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy.神经营养信号枢纽 B-Raf 的损伤导致脊髓性肌萎缩症中的运动神经元变性。
Proc Natl Acad Sci U S A. 2021 May 4;118(18). doi: 10.1073/pnas.2007785118.
7
Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development.脊髓性肌萎缩症与肌萎缩侧索硬化症之间的致病共性:通往治疗发展的汇聚之路。
Eur J Med Genet. 2018 Nov;61(11):685-698. doi: 10.1016/j.ejmg.2017.12.001. Epub 2017 Dec 5.
8
Motoneuron disease.运动神经元病
Handb Exp Pharmacol. 2014;220:411-41. doi: 10.1007/978-3-642-45106-5_15.
9
TransNeT-CGP: A cluster-based comorbid gene prioritization by integrating transcriptomics and network-topological features.TransNeT-CGP:基于聚类的共病基因优先级排序,整合了转录组学和网络拓扑特征。
Comput Biol Chem. 2024 Jun;110:108038. doi: 10.1016/j.compbiolchem.2024.108038. Epub 2024 Feb 27.
10
Corticomotoneuronal integrity and adaptation in spinal muscular atrophy.脊髓性肌萎缩症中皮质运动神经元的完整性与适应性
Arch Neurol. 2012 Apr;69(4):467-73. doi: 10.1001/archneurol.2011.1697.

引用本文的文献

1
The Role of mTOR in Amyotrophic Lateral Sclerosis.mTOR在肌萎缩侧索硬化症中的作用。
Biomedicines. 2025 Apr 13;13(4):952. doi: 10.3390/biomedicines13040952.
2
Amyotrophic Lateral Sclerosis (ALS): An Overview of Genetic and Metabolic Signaling Mechanisms.肌萎缩侧索硬化症(ALS):遗传和代谢信号传导机制概述
CNS Neurol Disord Drug Targets. 2025;24(2):83-90. doi: 10.2174/0118715273315891240801065231.
3
Biomarkers in 5q-associated spinal muscular atrophy-a narrative review.5q 相关脊髓性肌萎缩症的生物标志物:叙述性综述。

本文引用的文献

1
Mutation in senataxin alters the mechanism of R-loop resolution in amyotrophic lateral sclerosis 4.基因突变导致肌萎缩性侧索硬化症 4 型 R 环解旋机制改变。
Brain. 2022 Sep 14;145(9):3072-3094. doi: 10.1093/brain/awab464.
2
KLF15 overexpression in myocytes fails to ameliorate ALS-related pathology or extend the lifespan of SOD1G93A mice.肌细胞中 KLF15 的过表达未能改善 ALS 相关病理或延长 SOD1G93A 小鼠的寿命。
Neurobiol Dis. 2022 Jan;162:105583. doi: 10.1016/j.nbd.2021.105583. Epub 2021 Dec 11.
3
The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease.
J Neurol. 2023 Sep;270(9):4157-4178. doi: 10.1007/s00415-023-11787-y. Epub 2023 Jun 8.
4
Biological networks and complexity in early-onset motor neuron diseases.早发性运动神经元疾病中的生物网络与复杂性
Front Neurol. 2022 Oct 21;13:1035406. doi: 10.3389/fneur.2022.1035406. eCollection 2022.
5
R-loop Mediated DNA Damage and Impaired DNA Repair in Spinal Muscular Atrophy.R环介导的脊髓性肌萎缩症中的DNA损伤与DNA修复受损
Front Cell Neurosci. 2022 Jun 16;16:826608. doi: 10.3389/fncel.2022.826608. eCollection 2022.
JAK/STAT 信号通路在帕金森病治疗中的作用。
J Neuroimmunol. 2021 Dec 15;361:577758. doi: 10.1016/j.jneuroim.2021.577758. Epub 2021 Oct 28.
4
Metabolic Dysfunction in Spinal Muscular Atrophy.脊髓性肌萎缩症中的代谢功能障碍
Int J Mol Sci. 2021 May 31;22(11):5913. doi: 10.3390/ijms22115913.
5
Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.药物重定位:肌萎缩侧索硬化症的网络方法。
Neurotherapeutics. 2021 Jul;18(3):1678-1691. doi: 10.1007/s13311-021-01064-z. Epub 2021 May 13.
6
Investigation of Neuropathology after Nerve Release in Chronic Constriction Injury of Rat Sciatic Nerve.神经松解术治疗大鼠慢性坐骨神经缩窄损伤后的神经病理学研究。
Int J Mol Sci. 2021 Apr 29;22(9):4746. doi: 10.3390/ijms22094746.
7
Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy.神经营养信号枢纽 B-Raf 的损伤导致脊髓性肌萎缩症中的运动神经元变性。
Proc Natl Acad Sci U S A. 2021 May 4;118(18). doi: 10.1073/pnas.2007785118.
8
Non-neuronal cells in amyotrophic lateral sclerosis - from pathogenesis to biomarkers.肌萎缩侧索硬化症中的非神经元细胞——从发病机制到生物标志物。
Nat Rev Neurol. 2021 Jun;17(6):333-348. doi: 10.1038/s41582-021-00487-8. Epub 2021 Apr 29.
9
Spinal muscular atrophy: state of the art and new therapeutic strategies.脊髓性肌萎缩症:最新进展与新治疗策略
Neurol Sci. 2022 Dec;43(Suppl 2):615-624. doi: 10.1007/s10072-021-05258-3. Epub 2021 Apr 19.
10
Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies.肌萎缩侧索硬化症认识的最新进展及新兴疗法
Fac Rev. 2020 Nov 17;9:12. doi: 10.12703/b/9-12. eCollection 2020.